Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX) has a 33-report earnings history dating back to Aug 30, 2018. Its average absolute post-earnings move is ±4.61%, and 48.5% of those reactions were positive. Its largest post-earnings gain was +15.53% (Mar 30, 2022) and its largest decline was -13.94% (May 07, 2026). The next earnings report is predicted for 2026-11-09 (approximate).
Earnings reactions
How CRNX moved on each past earnings report.
Earnings Impact
Total Earnings
33
Avg Abs. Movement
±4.61%
Positive %
48.5%
Negative %
51.5%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 03, 2026 | ☽ POST | +0.16% | open_in_new |
| May 07, 2026 | ☽ POST | -13.94% | open_in_new |
| Feb 26, 2026 | ☽ POST | -6.04% | open_in_new |
| Nov 06, 2025 | ☽ POST | -8.02% | open_in_new |
Earnings Count
33
Total earnings in dataset
Avg Abs. Movement
±4.61%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 25-NSE | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
Frequently asked about CRNX earnings
When does Crinetics Pharmaceuticals, Inc. report earnings next? expand_more
Crinetics Pharmaceuticals, Inc. (CRNX)'s next earnings date is approximate for 2026-11-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CRNX stock move after earnings? expand_more
Over 33 reports, CRNX has moved an average of ±4.61% the session after earnings, closing higher 48.5% of the time.
What was CRNX's biggest post-earnings move? expand_more
CRNX's largest post-earnings gain on record was +15.53% on Mar 30, 2022, and its largest decline was -13.94% on May 07, 2026.
Where can I find Crinetics Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Crinetics Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right